Molbio Diagnostics
#Molbio
Good Q1FY27 in a off season Q1FY27
QoQ isn't comparable due to seasonality
100+cr EBITDA vs loss
Rev at 408cr vs 100cr
Q4 at 560cr
EBITDA at 101cr vs -15cr
Q4 at 158cr
PBT at 76cr vs -31cr
Q4 at 132cr
PAT at 53cr vs -24cr
Q4 at 96cr
FY26 PAT was 165cr out of which 96cr came in Q4FY26
Molbio Diagnostics
#Molbio
Good Q1FY27 in a off season Q1FY27
QoQ isn't comparable due to seasonality
100+cr EBITDA vs loss
Rev at 408cr vs 100cr
Q4 at 560cr
EBITDA at 101cr vs -15cr
Q4 at 158cr
PBT at 76cr vs -31cr
Q4 at 132cr
PAT at 53cr vs -24cr
Q4 at 96cr
FY26 PAT was 165cr out of which 96cr came in Q4FY26
That is my TV, and this is exactly what @sony_india want me to stop saying.
From their legal notice, para 8, word for word:
"you have also published defamatory statement(s) such as "Never buy a Sony BRAVIA" and "Sony sold us a warranty. Then refused it" on your X account. The said statements are false, misleading, derogatory, and defamatory on the face of it"
One customer's advice after a refused warranty. "Defamatory on the face of it."
@Sony I say once again proudly #DoNotBuySorryBravia
Full notice and my reply: https://t.co/mqUiXVPjyC
#SorryBravia